2017. Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis. Reumatismo. 69, 4 (Dec. 2017), 184–188. DOI:https://doi.org/10.4081/reumatismo.2017.1013.